Capozide Oral Tablet 25-15Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Capozide: Oral tablet (25-15mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file DrugItem_3234.JPG
Captopril/HCTZ 25mg-15mg Tab
Mylan Pharmaceuticals Inc
Pill Identification: M 81 
Drug Image file DrugItem_1829.JPG
Captopril/HCTZ 25mg-15mg Tab
Teva Pharmaceuticals USA Inc
Pill Identification: 93 176 
Drug Image file DrugItem_103.JPG
Captopril/HCTZ 25mg-15mg Tab
Ivax Pharmaceuticals Inc a Division of Teva USA
Pill Identification: LOGO 25/15 
Drug Image file DrugItem_6682.JPG
Capozide 25/15 Tab
Par Pharm
Pill Identification: CAPOZIDE 25/15 
Drug Image file DrugItem_791.JPG
Capozide 25/15 Tab
Bristol Myers Squibb Co
Pill Identification: CAPOZIDE 25/15 

What is this Medicine?

CAPTOPRIL; HYDROCHLOROTHIAZIDE (KAP toe pril; hye droe klor oh THYE a zide) is a combination of a diuretic and an ACE inhibitor. It is used to treat high blood pressure.

In-Depth Information
Select a Medication

Capozide 25/15 Tablet

NDC: 000030338
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Hypertension

Capozide 25/15 Tablet
Drug Image file DrugItem_791.JPG
Bristol Myers Squibb Co
Pill Identification: CAPOZIDE 25/15 
Shape: square
Color: orange,white

Reported Side Effects for Capozide 25/15 Tablet

Flushing Incidence:
<1.0%*
Severity: MILD
Onset: RAPID
Upset Stomach Incidence:
0.5-2.0%*
Severity: MILD
Onset: EARLY
Vomiting Incidence:
0.5-2.0%*
Severity: MILD
Onset: EARLY
Decreased Appetite Incidence:
0.5-2.0%*
Severity: MILD
Onset: DELAYED
Dry Mouth Incidence:
0.5-2.0%*
Severity: MILD
Onset: EARLY
Constipation Incidence:
0.5-2.0%*
Severity: MODERATE
Onset: DELAYED
Cough Incidence:
0.5-2.0%*
Severity: MILD
Onset: DELAYED
Loose Stools Incidence:
0.5-2.0%*
Severity: MILD
Onset: EARLY
Stomach Ulcer Incidence:
0.5-2.0%*
Severity: SEVERE
Onset: DELAYED
Stomach Pain Incidence:
0.5-2.0%*
Severity: MILD
Onset: EARLY
Shortness Of Breath Incidence:
0.5-2.0%*
Severity: MODERATE
Onset: EARLY
Rapid Heart Rate Incidence:
1.0%*
Severity: MODERATE
Onset: EARLY
Rapid Heart Rate Incidence:
1.0%*
Severity: MODERATE
Onset: RAPID
Chest Pain Incidence:
1.0%*
Severity: MODERATE
Onset: EARLY
Chest Pain Incidence:
1.0%*
Severity: MODERATE
Onset: EARLY
Itching Incidence:
2.0-7.0%*
Severity: MILD
Onset: RAPID
Metallic Taste Incidence:
2.0-4.0%*
Severity: MILD
Onset: EARLY
Rash With Pustules Incidence:
4.0-7.0%*
Severity: MILD
Onset: EARLY
Skin Redness Incidence:
4.0-7.0%*
Severity: MODERATE
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Daily Life Interactions for Capozide 25/15 Tablet

Elements of your daily lifestyle may have an effect on the medications you are taking. Drug interactions can result in unwanted side effects, reduce the effectiveness of your medicine or possibly increase the action of a particular medicine.

Moderate Lifestyle Interaction
Alcohol and Capozide 25/15 Tablet(Captopril)
Alcohol and Antihypertensives(Captopril)
Although an interaction is possible, Ethanol (alchohol) and Antihypertensive Agents (drugs used to reduce high blood pressure) may be used together. Ethanol or alchohol-containing beverages may increase the effects of Antihypertensive Agents on your blood pressure. If the blood pressure drops too low while taking Ethanol and Antihypertensive Agents, you may become dizzy or feel faint. To limit this interaction, avoid alcohol-containing beverages while taking medicines to lower your blood pressure. Do not stand or sit up too quickly. Contact your prescriber if you have dizziness which does not go away.
Pregnancy & Lactation Information
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

THIRD Trimester

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

Lactation

Compatible - This drug is generally safe to take by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Capozide

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5